News Listing

Filter by
Date
Feb 05, 2018 01:01 PM

John Mattick: Four ways precision medicine is making a diffe...

Precision medicine is fast becoming a reality – making it possible to analyse an individual’s genetic makeup and to use that information to select the best treatments. In this article, first published in The Conversation...

Feb 02, 2018 05:30 PM

Funding needed for rare cancer treatment and research

Professor David Thomas, Head of Garvan’s Cancer Division and leader of the Australian Genomic Cancer Medicine Program, recently spoke about the state of funding for those with rare cancer.

Feb 01, 2018 01:00 PM

Enabling faster genetic diagnosis for critically ill infants...

Critically unwell Australian babies and children with suspected genetic conditions will undergo rapid genomic testing to help guide their diagnosis and care as part of an Australia-first study, involving Garvan and its w...

Jan 26, 2018 06:29 AM

Australia Day Award for Garvan’s Dunia Alarkawi

Garvan researcher Dunia Alarkawi’s outstanding accomplishments have been acknowledged with an Australia Day Award from the National Council of Women of NSW.

Jan 24, 2018 01:30 PM

Researcher profile: Dr Marcia Munoz

Group Leader - Imaging and Inflammation

Jan 22, 2018 09:00 PM

Key support for Garvan’s cancer research in 2018 and beyond

Garvan researchers are thrilled to be among the recipients of grants in recently announced funding schemes from the National Breast Cancer Foundation and Cancer Australia. The funding will provide crucial support for a n...

MEDIA RELEASE: Jan 10, 2018 06:15 AM

When we exercise, our muscles and other organs communicate v...

Garvan researchers have shown, for the first time, that exercise allows the body’s tissues to communicate with each other using tiny protein-filled packages known as vesicles.

Jan 06, 2018 12:00 PM

Finding dormant cancer cells

A dormant cancer cell is like a ticking time bomb. It evades chemotherapy only to spontaneously wake and resume its deadly progress. Now, armed with pioneering tech and bold determination, researchers are finally beginni...

Dec 22, 2017 07:15 AM

Sheep cells provide clues to immunity

Garvan researchers have shed new light on the ‘danger signals’ that spur the immune system to attack invaders. The findings open the door to further research into improving vaccination methods and understanding and reduc...

Dec 14, 2017 05:30 PM

Rare cancer patients in ACT gain local access to Garvan’s cl...

The Australian Genomic Cancer Medicine Program, led by Garvan’s Professor David Thomas, will be expanded to the Canberra Region Cancer Centre.

Dec 06, 2017 04:49 PM

Rogue cells and more: 19 Garvan projects attract NHMRC fundi...

A project to track down ‘rogue’ cells in the blood of people with autoimmune disease is one of 19 Garvan research projects to be funded by NHMRC in its latest funding round. Announced today, the Project Grants total $13....

Dec 04, 2017 03:07 PM

Reading DNA in real time: Garvan’s new long-read sequencing ...

Garvan has added nanopore sequencing to its toolbox of systems to analyse human genomes, opening up new possibilities for research and deeper insights into the genetics of health and disease.

Nov 29, 2017 01:39 PM

Senate report a boost for research into low survival cancers...

Garvan welcomes the Senate Select Committee report into Funding for Research into Cancers with Low Survival Rates, tabled this week in Parliament.

Nov 23, 2017 09:37 AM

Small but mighty: the tiny molecules that regulate cancer ce...

A Garvan-led research team has performed the largest ever study of how ‘microRNAs’ function in cancer cells. Hundreds of these tiny molecules play an important role in whether cancer cells live or die, the researchers fo...

MEDIA RELEASE: Nov 16, 2017 06:46 AM

Pancreatic cancer: Avner Foundation awards major grants to i...

On World Pancreatic Cancer Day, the Avner Pancreatic Cancer Foundation has awarded grants of over $900,000 to Garvan's pancreatic cancer researchers. The grants will support ambitious new research into the 'matrix' surro...

Nov 14, 2017 02:52 PM

Pancreatic cancer: a lucky quirk in Ros’ DNA holds the key t...

In long-term survivors of pancreatic cancer, the immune system sees the cancer as an infectious disease – and so is empowered to attack and destroy tumour cells, according to new research from the US and Australia. This ...

MEDIA RELEASE: Nov 09, 2017 06:02 AM

Long-term survivors of pancreatic cancer have ‘built-in immu...

In long-term survivors of pancreatic cancer, the immune system sees the cancer as an infectious disease – and so is empowered to attack and destroy tumour cells, according to findings published today in Nature. The Austr...

MEDIA RELEASE: Nov 01, 2017 05:54 AM

Breakthrough breast cancer drug targets a major type of panc...

A newly approved breast cancer drug could be highly effective against some forms of pancreatic cancer, including metastatic cancer, Australian researchers have found.

Oct 31, 2017 04:30 PM

‘Connie’s Heart’ raises $110,000 for cancer research

The large-scale artwork ‘Connie’s Heart’, by Marie Ramos, has this week been unveiled at Garvan by Samuel Johnson OAM. Inspired by Connie Johnson and Love Your Sister, the artwork was a year in the making and has raised ...

MEDIA RELEASE: Oct 24, 2017 06:30 AM

DreamLab app speeding up Garvan’s cancer research

The DreamLab app, a distributed smartphone supercomputer, is now available on iOS and Android. Garvan and The Vodafone Foundation are now calling one million Australians to download the app and contribute to Garvan’s can...

MEDIA RELEASE: Oct 11, 2017 08:33 AM

Blockchain tech: Garvan partners with E-Nome

Garvan has signed a memorandum of understanding with E-Nome Pty Ltd, an Australian technology startup driving the application of blockchain technology to the secure storage of health records. Together, Garvan and E-Nome ...